{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:06:55Z","timestamp":1793290015128,"version":"4.5.0"},"reference-count":227,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ajog.2020.10.022","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T03:52:08Z","timestamp":1603165928000},"page":"S1019-S1034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":284,"special_numbering":"S","title":["Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders"],"prefix":"10.1016","volume":"226","author":[{"given":"Sarosh","family":"Rana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne D.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2281-6831","authenticated-orcid":false,"given":"S. Ananth","family":"Karumanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2020.10.022_bib1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.semnephrol.2004.07.009","article-title":"Strategies to prevent and treat preeclampsia: evidence from randomized controlled trials","volume":"24","author":"Villar","year":"2004","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.ajog.2020.10.022_bib2","doi-asserted-by":"crossref","first-page":"f6564","DOI":"10.1136\/bmj.f6564","article-title":"Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis","volume":"347","author":"Ananth","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2020.10.022_bib3","first-page":"147","article-title":"Preeclampsia: the role of angiogenic factors in its pathogenesis","volume":"24","author":"Wang","year":"2009","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.ajog.2020.10.022_bib4","first-page":"291","article-title":"The relation between hydatid moles, relative ischaemia of the gravid uterus and the placental origin of eclampsia","volume":"37","author":"Page","year":"1939","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-2007-976548","article-title":"Late postpartum eclampsia: report of two cases managed by uterine curettage and review of the literature","volume":"24","author":"Matsuo","year":"2007","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2020.10.022_bib6","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00404-013-2866-0","article-title":"Does immediate postpartum curettage of the endometrium accelerate recovery from preeclampsia-eclampsia? A randomized controlled trial","volume":"288","author":"Ragab","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2020.10.022_bib7","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1161\/CIRCULATIONAHA.109.853127","article-title":"Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease","volume":"123","author":"Powe","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2020.10.022_bib8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000146886","article-title":"Fetal vasculogenesis and angiogenesis in human placental villi","volume":"136","author":"Demir","year":"1989","journal-title":"Acta Anat (Basel)"},{"key":"10.1016\/j.ajog.2020.10.022_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.acthis.2007.02.008","article-title":"Vasculogenesis and angiogenesis in the early human placenta","volume":"109","author":"Demir","year":"2007","journal-title":"Acta Histochem"},{"key":"10.1016\/j.ajog.2020.10.022_bib10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000406847","article-title":"Ultrastructure of uteroplacental arteries","volume":"9","author":"De Wolf","year":"1982","journal-title":"Contrib Gynecol Obstet"},{"key":"10.1016\/j.ajog.2020.10.022_bib11","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/HYPERTENSIONAHA.113.01892","article-title":"Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: relationship to clinical outcome","volume":"62","author":"Lyall","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib12","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.placenta.2009.02.009","article-title":"Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy","volume":"30","author":"Burton","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2020.10.022_bib13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajog.2020.10.022_bib14","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1095\/biolreprod59.6.1540","article-title":"A\u00a0vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation","volume":"59","author":"Clark","year":"1998","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ajog.2020.10.022_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157584","article-title":"Association between placental lesions, cytokines and angiogenic factors in pregnant women with preeclampsia","volume":"11","author":"Weel","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2020.10.022_bib16","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050500202493","article-title":"Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin","volume":"18","author":"Bujold","year":"2005","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib18","doi-asserted-by":"crossref","first-page":"176.e1","DOI":"10.1016\/j.ajog.2007.03.036","article-title":"Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia","volume":"197","author":"Staff","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/10641955.2017.1329430","article-title":"The pathology of eclampsia: an autopsy series","volume":"36","author":"Hecht","year":"2017","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2020.10.022_bib20","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1111\/j.1523-1755.2005.00316.x","article-title":"Preeclampsia: a renal perspective","volume":"67","author":"Karumanchi","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajog.2020.10.022_bib21","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1126\/science.277.5332.1669","article-title":"Regulation of human placental development by oxygen tension","volume":"277","author":"Genbacev","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ajog.2020.10.022_bib22","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1161\/HYPERTENSIONAHA.120.14701","article-title":"T2\u2217 placental magnetic resonance imaging in preterm preeclampsia: an observational cohort study","volume":"75","author":"Ho","year":"2020","journal-title":"Hypertension"},{"issue":"4 Suppl","key":"10.1016\/j.ajog.2020.10.022_bib23","doi-asserted-by":"crossref","first-page":"S9.e1","DOI":"10.1016\/j.ajog.2015.08.003","article-title":"Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity","volume":"213","author":"Redman","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib24","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1471-0528.1994.tb13182.x","article-title":"A\u00a0study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies","volume":"101","author":"Meekins","year":"1994","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib25","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1080\/00016340601155056","article-title":"Screening for pre-eclampsia and small for gestational age fetuses at the 11-14 weeks scan by uterine artery Dopplers","volume":"86","author":"Pilalis","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2020.10.022_bib26","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1210\/jc.2005-0078","article-title":"Molecular evidence of placental hypoxia in preeclampsia","volume":"90","author":"Soleymanlou","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2020.10.022_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-pathol-121808-102149","article-title":"Pathogenesis of preeclampsia","volume":"5","author":"Young","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.ajog.2020.10.022_bib28","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.ki.5002175","article-title":"Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1","volume":"71","author":"Makris","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajog.2020.10.022_bib29","doi-asserted-by":"crossref","first-page":"R1085","DOI":"10.1152\/ajpregu.00794.2005","article-title":"Increased expression of sFlt-1 in in\u00a0vivo and in\u00a0vitro models of human placental hypoxia is mediated by HIF-1","volume":"291","author":"Nevo","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.ajog.2020.10.022_bib30","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1210\/en.2004-0533","article-title":"Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia","volume":"145","author":"Nagamatsu","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajog.2020.10.022_bib31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ajog.2019.05.044","article-title":"Placental bed research: I. The placental bed: from spiral arteries remodeling to the great obstetrical syndromes","volume":"221","author":"Brosens","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib32","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1161\/HYPERTENSIONAHA.107.096594","article-title":"Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression","volume":"50","author":"Gilbert","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib33","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.amjhyper.2006.12.016","article-title":"Effects of reduced uterine perfusion pressure on blood pressure and metabolic factors in pregnant rats","volume":"20","author":"Gilbert","year":"2007","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ajog.2020.10.022_bib34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.placenta.2017.03.001","article-title":"Uterine NK cells and macrophages in pregnancy","volume":"56","author":"Faas","year":"2017","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2020.10.022_bib35","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.4049\/jimmunol.0803769","article-title":"Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface","volume":"182","author":"Kalkunte","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajog.2020.10.022_bib36","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm1452","article-title":"Decidual NK cells regulate key developmental processes at the human fetal-maternal interface","volume":"12","author":"Hanna","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib37","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0143-4004(83)80043-5","article-title":"Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy","volume":"4","author":"Pijnenborg","year":"1983","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2020.10.022_bib38","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1172\/JCI68107","article-title":"Uterine NK cells: active regulators at the maternal-fetal interface","volume":"124","author":"Moffett","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajog.2020.10.022_bib39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1084\/jem.192.2.259","article-title":"Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy","volume":"192","author":"Ashkar","year":"2000","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib40","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1471-0528.1986.tb07830.x","article-title":"Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants","volume":"93","author":"Khong","year":"1986","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib41","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1172\/JCI119387","article-title":"Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?","volume":"99","author":"Zhou","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajog.2020.10.022_bib42","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1471-0528.1981.tb02222.x","article-title":"Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation","volume":"88","author":"Gerretsen","year":"1981","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib43","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI119388","article-title":"Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?","volume":"99","author":"Zhou","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajog.2020.10.022_bib44","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1096\/fj.12-210310","article-title":"Uterine natural killer cells initiate spiral artery remodeling in human pregnancy","volume":"26","author":"Robson","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.ajog.2020.10.022_bib45","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/01.HYP.0000188408.49896.c5","article-title":"Preeclampsia: recent insights","volume":"46","author":"Roberts","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib46","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1172\/JCI68991","article-title":"Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation","volume":"123","author":"Xiong","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajog.2020.10.022_bib47","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1084\/jem.20041214","article-title":"Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success","volume":"200","author":"Hiby","year":"2004","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib48","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/HYPERTENSIONAHA.111.182170","article-title":"Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia","volume":"59","author":"Rajakumar","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib49","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1126\/science.1111726","article-title":"Latest advances in understanding preeclampsia","volume":"308","author":"Redman","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ajog.2020.10.022_bib50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.placenta.2004.11.007","article-title":"Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction","volume":"27","author":"Goswami","year":"2006","journal-title":"Placenta"},{"issue":"Suppl","key":"10.1016\/j.ajog.2020.10.022_bib51","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.placenta.2011.12.006","article-title":"Review: does size matter? Placental debris and the pathophysiology of pre-eclampsia","volume":"33","author":"Redman","year":"2012","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2020.10.022_bib52","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cvr\/cvs007","article-title":"Microparticles: major transport vehicles for distinct microRNAs in circulation","volume":"93","author":"Diehl","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ajog.2020.10.022_bib53","doi-asserted-by":"crossref","first-page":"e56754","DOI":"10.1371\/journal.pone.0056754","article-title":"Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin","volume":"8","author":"Tannetta","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2020.10.022_bib54","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1038\/s41598-017-04468-0","article-title":"Syncytiotrophoblast derived extracellular vesicles transfer functional placental miRNAs to primary human endothelial cells","volume":"7","author":"Cronqvist","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajog.2020.10.022_bib55","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199803123381101","article-title":"Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"338","author":"Caritis","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib56","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.placenta.2016.04.006","article-title":"Revisiting decidual vasculopathy","volume":"42","author":"Hecht","year":"2016","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2020.10.022_bib57","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1471-0528.1986.tb08657.x","article-title":"The relation of birthweight to histological appearances in vessels of the placental bed","volume":"93","author":"McFadyen","year":"1986","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib58","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.placenta.2012.04.013","article-title":"Decidual vasculopathy and adverse perinatal outcome in preeclamptic pregnancy","volume":"33","author":"Stevens","year":"2012","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2020.10.022_bib59","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/14767058.2011.591461","article-title":"Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion","volume":"25","author":"Soto","year":"2012","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib60","doi-asserted-by":"crossref","first-page":"l2381","DOI":"10.1136\/bmj.l2381","article-title":"Pre-eclampsia: pathophysiology and clinical implications","volume":"366","author":"Burton","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2020.10.022_bib61","doi-asserted-by":"crossref","first-page":"12139","DOI":"10.1038\/s41598-017-11639-6","article-title":"FLT1 and transcriptome-wide polyadenylation site (PAS) analysis in preeclampsia","volume":"7","author":"Ashar-Patel","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajog.2020.10.022_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116508","article-title":"Large scale aggregate microarray analysis reveals three distinct molecular subclasses of human preeclampsia","volume":"10","author":"Leavey","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2020.10.022_bib63","doi-asserted-by":"crossref","first-page":"10705","DOI":"10.1073\/pnas.90.22.10705","article-title":"Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor","volume":"90","author":"Kendall","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajog.2020.10.022_bib64","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1161\/CIRCRESAHA.108.171504","article-title":"A\u00a0novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia","volume":"102","author":"Sela","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.ajog.2020.10.022_bib65","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1096\/fj.07-8809com","article-title":"Intronic polyadenylation signal sequences and alternate splicing generate human soluble Flt1 variants and regulate the abundance of soluble Flt1 in the placenta","volume":"21","author":"Thomas","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.ajog.2020.10.022_bib66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4939-7498-6_3","article-title":"Assessing the circulating placental-specific anti-angiogenic protein sFLT-1 e15a in preeclampsia","volume":"1710","author":"Palmer","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ajog.2020.10.022_bib67","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1210\/jc.2002-021942","article-title":"Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia","volume":"88","author":"Koga","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2020.10.022_bib68","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ajog.2004.03.043","article-title":"Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award","volume":"190","author":"Chaiworapongsa","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib69","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib70","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/14767050400028816","article-title":"Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia","volume":"17","author":"Chaiworapongsa","year":"2005","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib71","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/CIRCULATIONAHA.109.895458","article-title":"Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension","volume":"122","author":"Noori","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2020.10.022_bib72","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/01.AOG.0000264552.85436.a1","article-title":"Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia","volume":"109","author":"Wikstr\u00f6m","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib73","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1067\/mob.2003.111","article-title":"Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies","volume":"188","author":"Taylor","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib74","first-page":"1266","article-title":"Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia","volume":"101","author":"Polliotti","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib75","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/HYPERTENSIONAHA.120.15338","article-title":"Total versus free placental growth factor levels in the pathogenesis of preeclampsia","volume":"76","author":"Lecarpentier","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib76","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1210\/jc.2003-030528","article-title":"Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences","volume":"88","author":"Tsatsaris","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2020.10.022_bib77","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/01.RES.0000147365.86159.f5","article-title":"Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia","volume":"95","author":"Ahmad","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.ajog.2020.10.022_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119547","article-title":"Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice","volume":"10","author":"Szalai","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2020.10.022_bib79","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1161\/CIRCULATIONAHA.113.003215","article-title":"Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study","volume":"128","author":"Chappell","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2020.10.022_bib80","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fendo.2019.00165","article-title":"Human sFLT1 leads to severe changes in placental differentiation and vascularization in a transgenic hsFLT1\/rtTA FGR mouse model","volume":"10","author":"Vogtmann","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ajog.2020.10.022_bib81","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1073\/pnas.1011293108","article-title":"Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model","volume":"108","author":"Kumasawa","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajog.2020.10.022_bib82","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/j.1582-4934.2009.00820.x","article-title":"Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model","volume":"14","author":"Bergmann","year":"2010","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib83","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/HYPERTENSIONAHA.107.092098","article-title":"Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia","volume":"50","author":"Li","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib84","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/HYPERTENSIONAHA.109.141937","article-title":"Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension","volume":"55","author":"Gilbert","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib85","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1172\/JCI83918","article-title":"Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia","volume":"126","author":"Burke","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajog.2020.10.022_bib86","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1161\/HYPERTENSIONAHA.110.160481","article-title":"Suppression of the nitric oxide pathway in metastatic renal cell carcinoma patients receiving vascular endothelial growth factor-signaling inhibitors","volume":"56","author":"Robinson","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib87","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/MNH.0000000000000197","article-title":"Role of endothelin in preeclampsia and hypertension following antiangiogenesis treatment","volume":"25","author":"Saleh","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.ajog.2020.10.022_bib88","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1681\/ASN.2013030291","article-title":"Hydrogen sulfide attenuates sFlt1-induced hypertension and renal damage by upregulating vascular endothelial growth factor","volume":"25","author":"Holwerda","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ajog.2020.10.022_bib89","doi-asserted-by":"crossref","first-page":"9904","DOI":"10.1074\/jbc.M412017200","article-title":"Vascular endothelial growth factor (VEGF)-A165-induced prostacyclin synthesis requires the activation of VEGF receptor-1 and -2 heterodimer","volume":"280","author":"Neagoe","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ajog.2020.10.022_bib90","doi-asserted-by":"crossref","first-page":"184.e1","DOI":"10.1016\/j.ajog.2009.09.005","article-title":"Angiogenic dysfunction in molar pregnancy","volume":"202","author":"Kanter","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib91","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.fertnstert.2009.02.015","article-title":"Elevated serum soluble fms-like tyrosine kinase 1 (sFlt1) level in women with hydatidiform mole","volume":"94","author":"Koga","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2020.10.022_bib92","doi-asserted-by":"crossref","first-page":"428.e1","DOI":"10.1016\/j.ajog.2007.10.783","article-title":"Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?","volume":"198","author":"Bdolah","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib93","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ajog.2005.06.031","article-title":"Circulating angiogenic proteins in trisomy 13","volume":"194","author":"Bdolah","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib94","doi-asserted-by":"crossref","first-page":"546.e1","DOI":"10.1016\/j.ajog.2011.02.027","article-title":"Placental expression of angiogenic factors in Trisomy 13","volume":"204","author":"Silasi","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib95","doi-asserted-by":"crossref","first-page":"108.e1","DOI":"10.1016\/j.ajog.2015.09.066","article-title":"Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study","volume":"214","author":"Kim","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib96","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/10641955.2013.837175","article-title":"The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes","volume":"33","author":"Cohen","year":"2014","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2020.10.022_bib97","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/ng.3895","article-title":"Variants in the fetal genome near FLT1 are associated with risk of preeclampsia","volume":"49","author":"McGinnis","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajog.2020.10.022_bib98","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/HYPERTENSIONAHA.120.15346","article-title":"C-allele of rs4769613 near FLT1 represents a high-confidence placental risk factor for preeclampsia","volume":"76","author":"Kikas","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib99","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib100","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/jnci\/djm311","article-title":"A\u00a0preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib","volume":"100","author":"Patel","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2020.10.022_bib101","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.bjc.6603813","article-title":"Mechanisms of adverse effects of anti-VEGF therapy for cancer","volume":"96","author":"Kamba","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2020.10.022_bib102","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nature10897","article-title":"Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancy","volume":"484","author":"Cui","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2020.10.022_bib103","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nature06951","article-title":"Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia","volume":"453","author":"Kanasaki","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2020.10.022_bib104","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.preghy.2016.06.004","article-title":"Trophoblast mitochondrial function is impaired in preeclampsia and correlates negatively with the expression of soluble fms-like tyrosine kinase 1","volume":"6","author":"Zsengell\u00e9r","year":"2016","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2020.10.022_bib105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/01.RES.0000254703.11154.18","article-title":"Angiotensin II induces soluble fms-like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy","volume":"100","author":"Zhou","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.ajog.2020.10.022_bib106","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.siny.2006.04.001","article-title":"Inflammation and pre-eclampsia","volume":"11","author":"Borzychowski","year":"2006","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib107","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1161\/CIRCULATIONAHA.106.660134","article-title":"Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1","volume":"115","author":"Cudmore","year":"2007","journal-title":"Circulation"},{"issue":"Suppl 2","key":"10.1016\/j.ajog.2020.10.022_bib108","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0049-3848(09)70020-9","article-title":"Angiogenic factors and preeclampsia","volume":"123","author":"Steinberg","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajog.2020.10.022_bib109","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/rep.1.01076","article-title":"TGF-beta superfamily expression and actions in the endometrium and placenta","volume":"132","author":"Jones","year":"2006","journal-title":"Reproduction"},{"key":"10.1016\/j.ajog.2020.10.022_bib110","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib111","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1084\/jem.20072041","article-title":"VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma","volume":"205","author":"Maharaj","year":"2008","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib112","doi-asserted-by":"crossref","first-page":"17800","DOI":"10.1073\/pnas.1816661116","article-title":"Role of soluble endoglin in BMP9 signaling","volume":"116","author":"Lawera","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajog.2020.10.022_bib113","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/10641955.2013.835820","article-title":"Hypertension, inflammation and T lymphocytes are increased in a rat model of HELLP syndrome","volume":"33","author":"Wallace","year":"2014","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2020.10.022_bib114","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.semnephrol.2004.07.011","article-title":"Animal models of preeclampsia","volume":"24","author":"Podjarny","year":"2004","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.ajog.2020.10.022_bib115","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1161\/HYPERTENSIONAHA.108.115006","article-title":"Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia","volume":"52","author":"Sandrim","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib116","doi-asserted-by":"crossref","first-page":"152.e1","DOI":"10.1016\/j.ajog.2010.08.049","article-title":"Circulating angiogenic and antiangiogenic factors in women with eclampsia","volume":"204","author":"Vaisbuch","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib117","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3109\/14767050903184207","article-title":"The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome","volume":"23","author":"Young","year":"2010","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib118","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/aje\/kwq373","article-title":"Angiogenic factors in maternal circulation and the risk of severe fetal growth restriction","volume":"173","author":"\u00c5svold","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2020.10.022_bib119","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.placenta.2019.02.014","article-title":"Plasma concentrations of soluble endoglin in the maternal circulation are associated with maternal vascular malperfusion lesions in the placenta of women with preeclampsia","volume":"78","author":"Schmella","year":"2019","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2020.10.022_bib120","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1471-2393-13-82","article-title":"Variation in endoglin pathway genes is associated with preeclampsia: a case-control candidate gene association study","volume":"13","author":"Bell","year":"2013","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ajog.2020.10.022_bib121","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.clinbiochem.2010.02.010","article-title":"Multicenter evaluation of the first automated Elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia","volume":"43","author":"Schiettecatte","year":"2010","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ajog.2020.10.022_bib122","doi-asserted-by":"crossref","first-page":"40.e1","DOI":"10.1016\/j.ajog.2009.07.025","article-title":"Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study","volume":"202","author":"Sunderji","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib123","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/HYPERTENSIONAHA.112.201459","article-title":"Differential diagnosis of preeclampsia: remember the soluble fms-like tyrosine kinase 1\/placental growth factor ratio","volume":"60","author":"Verdonk","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib124","doi-asserted-by":"crossref","first-page":"161.e1","DOI":"10.1016\/j.ajog.2009.09.016","article-title":"An automated method for the determination of the sFlt-1\/PIGF ratio in the assessment of preeclampsia","volume":"202","author":"Verlohren","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/uog.19051","article-title":"Comparison of three commercially available placental growth factor-based tests in women with suspected preterm pre-eclampsia: the COMPARE study","volume":"53","author":"McCarthy","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib126","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1161\/HYPERTENSIONAHA.119.13997","article-title":"Angiogenic marker prognostic models in pregnant women with hypertension","volume":"75","author":"Perry","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib127","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/AOG.0000000000003694","article-title":"Placental growth factor and the risk of adverse neonatal and maternal outcomes","volume":"135","author":"Parchem","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib128","doi-asserted-by":"crossref","first-page":"6270187","DOI":"10.1155\/2019\/6270187","article-title":"Maternal serum angiogenic factor sFlt-1 to PlGF ratio in preeclampsia: a useful marker for differential diagnosis and prognosis evaluation in Chinese women","volume":"2019","author":"Lou","year":"2019","journal-title":"Dis Markers"},{"key":"10.1016\/j.ajog.2020.10.022_bib129","first-page":"261","article-title":"Prediction of adverse outcomes by common definitions of hypertension in pregnancy","volume":"97","author":"Zhang","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib130","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/AOG.0000000000000746","article-title":"Pregnancy-related mortality in California: causes, characteristics, and improvement opportunities","volume":"125","author":"Main","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib131","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3109\/14767058.2011.589932","article-title":"Maternal plasma concentrations of angiogenic\/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia","volume":"24","author":"Chaiworapongsa","year":"2011","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib132","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib133","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.preghy.2018.05.008","article-title":"Angiogenic biomarkers in triage and risk for preeclampsia with severe features","volume":"13","author":"Rana","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2020.10.022_bib134","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/HYPERTENSIONAHA.119.12760","article-title":"Short-term prediction of adverse outcomes using the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor) ratio in Asian women with suspected preeclampsia","volume":"74","author":"Bian","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib135","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/uog.19178","article-title":"Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting","volume":"53","author":"Zeisler","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib136","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2020.10.022_bib137","doi-asserted-by":"crossref","first-page":"259.e1","DOI":"10.1016\/j.ajog.2019.09.003","article-title":"Placental growth factor predicts time to delivery in women with signs or symptoms of early preterm preeclampsia: a prospective multicenter study","volume":"222","author":"Barton","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib138","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/AOG.0000000000001525","article-title":"Soluble fms-like tyrosine kinase-1-to-placental growth factor ratio and time to delivery in women with suspected preeclampsia","volume":"128","author":"Zeisler","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib139","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/14767058.2013.806905","article-title":"Plasma concentrations of angiogenic\/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study","volume":"27","author":"Chaiworapongsa","year":"2014","journal-title":"J\u00a0Matern Fetal Neonat Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib140","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.3109\/14767058.2012.713055","article-title":"Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia","volume":"25","author":"Moore","year":"2012","journal-title":"J\u00a0Matern Fetal Neonat Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib141","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/10641955.2013.784788","article-title":"Clinical characterization and outcomes of preeclampsia with normal angiogenic profile","volume":"32","author":"Rana","year":"2013","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2020.10.022_bib142","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/HYPERTENSIONAHA.111.181735","article-title":"Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy","volume":"59","author":"Perni","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib143","first-page":"631","article-title":"Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus","volume":"35","author":"Qazi","year":"2008","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ajog.2020.10.022_bib144","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ki.2012.348","article-title":"Chronic kidney disease may be differentially diagnosed from preeclampsia by serum biomarkers","volume":"83","author":"Rolfo","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajog.2020.10.022_bib145","doi-asserted-by":"crossref","first-page":"58.e1","DOI":"10.1016\/j.ajog.2011.07.037","article-title":"The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients","volume":"206","author":"Verlohren","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib146","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/uog.14799","article-title":"Implementation of the sFlt-1\/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice","volume":"45","author":"Stepan","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib147","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126815","article-title":"Circulating angiogenic factors and the risk of adverse outcomes among Haitian women with preeclampsia","volume":"10","author":"March","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2020.10.022_bib148","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1080\/14767058.2016.1212832","article-title":"Angiogenic imbalance as a contributor to the pathophysiology of preeclampsia among black African women","volume":"30","author":"Meeme","year":"2017","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib149","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.placenta.2014.04.013","article-title":"Soluble fms-like tyrosine kinase-1 in HIV infected pre-eclamptic South African black women","volume":"35","author":"Govender","year":"2014","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2020.10.022_bib150","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5830\/CVJA-2012-003","article-title":"The role of angiogenic, anti-angiogenic and vasoactive factors in pre-eclamptic African women: early- versus late-onset pre-eclampsia","volume":"23","author":"Govender","year":"2012","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.ajog.2020.10.022_bib151","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0140-6736(18)33212-4","article-title":"Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial","volume":"393","author":"Duhig","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.10.022_bib152","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/HYPERTENSIONAHA.119.12739","article-title":"Randomized interventional study on prediction of preeclampsia\/eclampsia in women with suspected preeclampsia: INSPIRE","volume":"74","author":"Cerdeira","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib153","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.preghy.2020.05.013","article-title":"Evaluation of angiogenic factors in the decision to admit women with suspected preeclampsia","volume":"21","author":"Suresh","year":"2020","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2020.10.022_bib154","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3109\/14767050903366119","article-title":"Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice","volume":"23","author":"Ogg\u00e8","year":"2010","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib155","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1373\/clinchem.2011.169094","article-title":"The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia","volume":"58","author":"Hagmann","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajog.2020.10.022_bib156","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050701830480","volume":"21","author":"Romero","year":"2008","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib157","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/14767050902994754","article-title":"A\u00a0prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia","volume":"22","author":"Kusanovic","year":"2009","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib158","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/HYPERTENSIONAHA.116.08620","article-title":"Prediction of preeclampsia using the soluble fms-like tyrosine kinase 1 to placental growth factor ratio: a prospective cohort study of unselected nulliparous women","volume":"69","author":"Sovio","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib159","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1210\/jc.2003-031244","article-title":"First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia","volume":"89","author":"Thadhani","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2020.10.022_bib160","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1067\/mob.2003.343","article-title":"First-trimester sex hormone binding globulin and subsequent gestational diabetes mellitus","volume":"189","author":"Thadhani","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib161","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1161\/HYPERTENSIONAHA.108.127977","article-title":"First-trimester prediction of hypertensive disorders in pregnancy","volume":"53","author":"Poon","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib162","article-title":"First trimester preeclampsia screening and prediction","author":"Chaemsaithong","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib163","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jama.293.1.77","article-title":"Urinary placental growth factor and risk of preeclampsia","volume":"293","author":"Levine","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2020.10.022_bib164","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.ki.5000075","article-title":"Low urinary placental growth factor is a marker of pre-eclampsia","volume":"69","author":"Aggarwal","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajog.2020.10.022_bib165","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/AOG.0000000000003547","article-title":"Urinary placental growth factor for prediction of placental adverse outcomes in high-risk pregnancies","volume":"134","author":"Lecarpentier","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib166","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ajog.2017.04.032","article-title":"Short-term costs of preeclampsia to the United States health care system","volume":"217","author":"Stevens","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib167","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/1471-0528.12259","article-title":"Cost and resource implications with serum angiogenic factor estimation in the triage of pre-eclampsia","volume":"120","author":"Schnettler","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2020.10.022_bib168","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/uog.15997","article-title":"sFlt-1\/PlGF ratio test for pre-eclampsia: an economic assessment for the UK","volume":"48","author":"Vatish","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib169","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/1471-0528.15855","article-title":"Placental growth factor testing for suspected pre-eclampsia: a cost-effectiveness analysis","volume":"126","author":"Duhig","year":"2019","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2020.10.022_bib170","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/HYPERTENSIONAHA.109.143933","article-title":"Inching towards a targeted therapy for preeclampsia","volume":"55","author":"Thadhani","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib171","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/CIRCULATIONAHA.111.034793","article-title":"Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia","volume":"124","author":"Thadhani","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2020.10.022_bib172","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1681\/ASN.2015020157","article-title":"Removal of soluble fms-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia","volume":"27","author":"Thadhani","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ajog.2020.10.022_bib173","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.4297","article-title":"RNAi modulation of placental sFLT1 for the treatment of preeclampsia","author":"Turanov","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ajog.2020.10.022_bib174","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/HYPERTENSIONAHA.115.05445","article-title":"Effects of pravastatin on human placenta, endothelium, and women with severe preeclampsia","volume":"66","author":"Brownfoot","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib175","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1161\/HYPERTENSIONAHA.114.03115","article-title":"Clinical improvement and successful pregnancy in a preeclamptic patient with antiphospholipid syndrome treated with pravastatin","volume":"63","author":"Lefkou","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib176","doi-asserted-by":"crossref","first-page":"720.e1","DOI":"10.1016\/j.ajog.2015.12.038","article-title":"Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial","volume":"214","author":"Costantine","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib177","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1096\/fj.12-221648","article-title":"A\u00a0higher maternal choline intake among third-trimester pregnant women lowers placental and circulating concentrations of the antiangiogenic factor fms-like tyrosine kinase-1 (sFLT1)","volume":"27","author":"Jiang","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.ajog.2020.10.022_bib178","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.placenta.2015.01.004","article-title":"Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1","volume":"36","author":"Li","year":"2015","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2020.10.022_bib179","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jri.2017.10.044","article-title":"The effect of acetyl salicylic acid (aspirin) on trophoblast-endothelial interaction in\u00a0vitro","volume":"124","author":"Xu","year":"2017","journal-title":"J\u00a0Reprod Immunol"},{"key":"10.1016\/j.ajog.2020.10.022_bib180","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1097\/HJH.0000000000002185","article-title":"Aspirin enhances trophoblast invasion and represses soluble fms-like tyrosine kinase 1 production: a putative mechanism for preventing preeclampsia","volume":"37","author":"Su","year":"2019","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ajog.2020.10.022_bib181","first-page":"1429","article-title":"Effect of low-dose aspirin on soluble FMS-like tyrosine kinase 1\/placental growth factor (sFlt-1\/PlGF ratio) in pregnancies at high risk for the development of preeclampsia","volume":"8","author":"Mayer-Pickel","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib182","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1210\/jc.2004-1955","article-title":"Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor","volume":"90","author":"Shibata","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2020.10.022_bib183","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3109\/14767058.2015.1048431","article-title":"The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia","volume":"29","author":"Chaiworapongsa","year":"2016","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib184","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejogrb.2019.08.007","article-title":"A\u00a0prediction model for short-term neonatal outcomes in severe early-onset fetal growth restriction","volume":"241","author":"Sharp","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2020.10.022_bib185","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S2352-4642(18)30129-9","article-title":"Screening for fetal growth restriction using ultrasound and the sFLT1\/PlGF ratio in nulliparous women: a prospective cohort study","volume":"2","author":"Gaccioli","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.ajog.2020.10.022_bib186","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/14767050701413022","article-title":"Unexplained fetal death: another anti-angiogenic state","volume":"20","author":"Espinoza","year":"2007","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib187","doi-asserted-by":"crossref","first-page":"287.e1","DOI":"10.1016\/j.ajog.2013.01.016","article-title":"Maternal plasma concentrations of angiogenic\/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia","volume":"208","author":"Chaiworapongsa","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib188","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3109\/14767050903443467","article-title":"Unexplained fetal death is associated with increased concentrations of anti-angiogenic factors in amniotic fluid","volume":"23","author":"Chaiworapongsa","year":"2010","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib189","doi-asserted-by":"crossref","first-page":"682.e1","DOI":"10.1016\/j.ajog.2017.10.001","article-title":"The prediction of fetal death with a simple maternal blood test at 20\u201324 weeks: a role for angiogenic index-1 (PlGF\/sVEGFR-1 ratio)","volume":"217","author":"Chaiworapongsa","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib190","doi-asserted-by":"crossref","first-page":"310.e1","DOI":"10.1016\/j.ajog.2013.01.017","article-title":"Evidence of an imbalance of angiogenic\/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death","volume":"208","author":"Whitten","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib191","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1210\/jc.2009-1954","article-title":"Change in amniotic fluid levels of multiple anti-angiogenic proteins before development of preeclampsia and intrauterine growth restriction","volume":"95","author":"Wang","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2020.10.022_bib192","doi-asserted-by":"crossref","first-page":"L36","DOI":"10.1152\/ajplung.00294.2011","article-title":"Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia","volume":"302","author":"Tang","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.ajog.2020.10.022_bib193","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jpeds.2009.10.018","article-title":"Maternal preeclampsia predicts the development of bronchopulmonary dysplasia","volume":"156","author":"Hansen","year":"2010","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ajog.2020.10.022_bib194","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/CIRCULATIONAHA.110.941203","article-title":"Pulmonary and systemic vascular dysfunction in young offspring of mothers with preeclampsia","volume":"122","author":"Jayet","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2020.10.022_bib195","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3109\/10641955.2012.697951","article-title":"Severe myocardial impairment and chamber dysfunction in preterm preeclampsia","volume":"31","author":"Melchiorre","year":"2012","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2020.10.022_bib196","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/14767058.2017.1396312","article-title":"Fetal hydrops and the risk of severe preeclampsia","volume":"32","author":"Burwick","year":"2019","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib197","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/10641955.2011.638959","article-title":"Placental origins of angiogenic dysfunction in mirror syndrome","volume":"31","author":"Bixel","year":"2012","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2020.10.022_bib198","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1056\/NEJMc052721","article-title":"Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops","volume":"354","author":"Stepan","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib199","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ejogrb.2011.04.049","article-title":"sFlt-1 and PlGF levels in a patient with mirror syndrome related to cytomegalovirus infection","volume":"158","author":"De Oliveira","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2020.10.022_bib200","doi-asserted-by":"crossref","first-page":"omx112","DOI":"10.1093\/omcr\/omx112","article-title":"Elevation of maternal serum sFlt-1 in pregnancy with mirror syndrome caused by fetal cardiac failure","volume":"2018","author":"Katoh","year":"2018","journal-title":"Oxf Med Case Reports"},{"key":"10.1016\/j.ajog.2020.10.022_bib201","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000348778","article-title":"Normalisation of angiogenic imbalance after intra-uterine transfusion for mirror syndrome caused by parvovirus B19","volume":"34","author":"Goa","year":"2013","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2020.10.022_bib202","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1053\/plac.2001.0710","article-title":"Placental vascular anastomoses visualized during fetoscopic laser surgery in severe mid-trimester twin-twin transfusion syndrome","volume":"22","author":"Diehl","year":"2001","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2020.10.022_bib203","doi-asserted-by":"crossref","first-page":"141.e1","DOI":"10.1016\/j.ajog.2013.09.022","article-title":"Circulating angiogenic factors in monochorionic twin pregnancies complicated by twin-to-twin transfusion syndrome and selective intrauterine growth restriction","volume":"210","author":"Yinon","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib204","doi-asserted-by":"crossref","first-page":"382.e1","DOI":"10.1016\/j.ajog.2008.02.016","article-title":"Twin-to-twin transfusion syndrome: an antiangiogenic state?","volume":"198","author":"Kusanovic","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib205","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/uog.7515","article-title":"Maternal plasma and amniotic fluid angiogenic factors and their receptors in monochorionic twin pregnancies complicated by twin-to-twin transfusion syndrome","volume":"35","author":"Fox","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.022_bib206","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1080\/14767058.2017.1309020","article-title":"The impact of laser surgery on angiogenic and anti-angiogenic factors in twin-twin transfusion syndrome: a prospective study","volume":"31","author":"Chon","year":"2018","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib207","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1161\/CIRCULATIONAHA.115.015721","article-title":"Epidemiology and mechanisms of de novo and persistent hypertension in the postpartum period","volume":"132","author":"Goel","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2020.10.022_bib208","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/HYPERTENSIONAHA.118.12205","article-title":"Angiogenic factor estimation as a warning sign of preeclampsia-related peripartum morbidity among hospitalized patients","volume":"73","author":"Lopes Perdigao","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib209","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1161\/HYPERTENSIONAHA.116.07252","article-title":"Circulating antiangiogenic factors and myocardial dysfunction in hypertensive disorders of pregnancy","volume":"67","author":"Shahul","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib210","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/HYPERTENSIONAHA.117.09256","article-title":"Angiogenic markers and cardiovascular indices in the prediction of hypertensive disorders of pregnancy","volume":"69","author":"Verlohren","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib211","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/HYPERTENSIONAHA.118.10888","article-title":"Activin A and late postpartum cardiac dysfunction among women with hypertensive disorders of pregnancy","volume":"72","author":"Shahul","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib212","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.preghy.2017.10.009","article-title":"Abnormal mid-trimester cardiac strain in women with chronic hypertension predates superimposed preeclampsia","volume":"10","author":"Shahul","year":"2017","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2020.10.022_bib213","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/CIRCULATIONAHA.115.020491","article-title":"Peripartum cardiomyopathy","volume":"133","author":"Arany","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2020.10.022_bib214","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.jacc.2013.08.717","article-title":"The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis","volume":"62","author":"Bello","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ajog.2020.10.022_bib215","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.echo.2014.11.018","article-title":"Global longitudinal strain and global circumferential strain by speckle-tracking echocardiography and feature-tracking cardiac magnetic resonance imaging: comparison with left ventricular ejection fraction","volume":"28","author":"Onishi","year":"2015","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.ajog.2020.10.022_bib216","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature11040","article-title":"Cardiac angiogenic imbalance leads to peripartum cardiomyopathy","volume":"485","author":"Patten","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2020.10.022_bib217","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/cvr\/cvu018","article-title":"Pre-eclampsia and cardiovascular disease","volume":"101","author":"Chen","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ajog.2020.10.022_bib218","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0140-6736(05)67726-4","article-title":"Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study","volume":"366","author":"Ray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.10.022_bib219","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/HYPERTENSIONAHA.110.150078","article-title":"Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort","volume":"56","author":"Mongraw-Chaffin","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib220","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/bmj.323.7323.1213","article-title":"Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study","volume":"323","author":"Irgens","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2020.10.022_bib221","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/CIRCULATIONAHA.110.943407","article-title":"Hypertension in pregnancy and later cardiovascular risk: common antecedents?","volume":"122","author":"Romundstad","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2020.10.022_bib222","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJM196408202710803","article-title":"Late vascular effects of toxemia of pregnancy","volume":"271","author":"Epstein","year":"1964","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.10.022_bib223","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/heartjnl-2016-309671","article-title":"Recurrent pre-eclampsia and subsequent cardiovascular risk","volume":"103","author":"Auger","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.ajog.2020.10.022_bib224","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/HYPERTENSIONAHA.114.04971","article-title":"Exposure to experimental preeclampsia in mice enhances the vascular response to future injury","volume":"65","author":"Pruthi","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.022_bib225","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1161\/CIRCULATIONAHA.118.036632","article-title":"Placental growth factor as an indicator of maternal cardiovascular risk after pregnancy","volume":"139","author":"Benschop","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2020.10.022_bib226","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1681\/ASN.2007020255","article-title":"The glomerular injury of preeclampsia","volume":"18","author":"Stillman","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ajog.2020.10.022_bib227","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.placenta.2010.03.002","article-title":"Cellular and molecular regulation of spiral artery remodelling: lessons from the cardiovascular field","volume":"31","author":"Whitley","year":"2010","journal-title":"Placenta"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820311960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820311960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:38:18Z","timestamp":1757590698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937820311960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":227,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0002937820311960"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2020.10.022","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2020.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}